Publications by authors named "Michael Pantze"

Claim this Profile
M
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration.
Yanan Zheng, Devin B Tesar, Lisa Benincosa, Herbert Birnböck, C Andrew Boswell, Michael Pantze

MAbs· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer.
Hilary Calvert, Chris Twelves, Malcolm Ranson, Ruth Plummer, Scott Fettner, Michael Pantze

Anticancer Drugs· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys.
Olaf Kuhlmann, Axel Paehler, Idelette Weick, Christoph Funk, Michael Pantze

Xenobiotica· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibition.
Ashok Rakhit, Michael P Pantze, Scott Fettner, Hannah M Jones, Jean-Eric Charoin

Eur J Clin Pharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and excretion of erlotinib, a small molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers.
Jie Ling, Kim A Johnson, Zhuang Miao, Ashok Rakhit, Michael P Pantze

Drug Metab Dispos· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis